| http://www.w3.org/ns/prov#value | - Another embodiment of the present invention is a method of identifying an agent that modulates EGFR- or IGF-IR-mediated disorders through the binding of an anti-EGFR or anti-IGF-IR polypeptide or anti-IGF-IR polypeptide respectively as described above to EGFR or IGF-IR comp
|
